These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2195576)

  • 21. A double blind comparison of alprazolam and amitriptyline hydrochloride in the treatment of nonpsychotic depression.
    Singh AN; Nair NP; Suranyi-Cadotte B; Schwartz G; Lizondo E
    Can J Psychiatry; 1988 Apr; 33(3):218-22. PubMed ID: 3289717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emergence of depressive symptoms in patients receiving alprazolam for panic disorder.
    Lydiard RB; Laraia MT; Ballenger JC; Howell EF
    Am J Psychiatry; 1987 May; 144(5):664-5. PubMed ID: 3578580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical outcome and adverse effect profile associated with concurrent administration of alprazolam and imipramine.
    Wells BG; Evans RL; Ereshefsky L; Antal EJ; Lobeck F; Rawls WN; Hamann G; Grimmig J; Smith RB
    J Clin Psychiatry; 1988 Oct; 49(10):394-9. PubMed ID: 3049560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative studies of pharmacotherapy for school refusal.
    Bernstein GA; Garfinkel BD; Borchardt CM
    J Am Acad Child Adolesc Psychiatry; 1990 Sep; 29(5):773-81. PubMed ID: 2228932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-blind comparative study of desipramine hydrochloride and diazepam in the control of mixed anxiety/depression symptomatology.
    Kleber RJ
    J Clin Psychiatry; 1979 Apr; 40(4):165-70. PubMed ID: 370109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alprazolam in the treatment of panic attack patients with and without major depression.
    Pyke RE; Kraus M
    J Clin Psychiatry; 1988 Feb; 49(2):66-8. PubMed ID: 3338978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The influence of alprazolam on the symptoms of anxiety and depression].
    Małyszczak K; Kiejna A
    Psychiatr Pol; 1997; 31(6):745-52. PubMed ID: 9515306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alprazolam in clinically anxious patients with depressed mood.
    Aden GC
    J Clin Psychiatry; 1983 Jan; 44(1):22-4. PubMed ID: 6130082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Etizolam in the treatment of generalized anxiety disorder: a controlled clinical trial.
    Bertolino A; Mastucci E; Porro V; Corfiati L; Palermo M; Ecari U; Ceccarelli G
    J Int Med Res; 1989; 17(5):455-60. PubMed ID: 2572494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
    Lydiard RB; Ballenger JC; Rickels K
    J Clin Psychiatry; 1997; 58 Suppl 11():11-8. PubMed ID: 9363043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prescription-event monitoring of 10,895 patients treated with alprazolam.
    Edwards JG; Inman WH; Pearce GL; Rawson NS
    Br J Psychiatry; 1991 Mar; 158():387-92. PubMed ID: 2036539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of chronic antidepressant treatment with adinazolam and desipramine on melatonin output.
    Kennedy SH; Brown GM
    Psychiatry Res; 1992 Aug; 43(2):177-85. PubMed ID: 1410073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Double-blind comparative study of alprazolam (Xanax) and amitriptyline in the treatment of anxiety associated with depression].
    Bernardi F; Cairoli S; D'Aurizio C; De Rosa A; Grasso A; Sannino V; Savoldi F; Sorge F; Casadei GL
    Minerva Psichiatr; 1988; 29(4):203-10. PubMed ID: 3074234
    [No Abstract]   [Full Text] [Related]  

  • 34. A quantitative neuromotor predictor of antidepressant non-response in patients with major depression.
    Caligiuri MP; Gentili V; Eberson S; Kelsoe J; Rapaport M; Gillin JC
    J Affect Disord; 2003 Nov; 77(2):135-41. PubMed ID: 14607390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alprazolam-induced hypomania.
    Reddy J; Khanna S; Anand U; Banerjee A
    Aust N Z J Psychiatry; 1996 Aug; 30(4):550-2. PubMed ID: 8887708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alprazolam, diazepam, imipramine, and placebo in outpatients with major depression.
    Rickels K; Chung HR; Csanalosi IB; Hurowitz AM; London J; Wiseman K; Kaplan M; Amsterdam JD
    Arch Gen Psychiatry; 1987 Oct; 44(10):862-6. PubMed ID: 3310952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antidepressant pharmacotherapy of depression associated with multiple sclerosis.
    Schiffer RB; Wineman NM
    Am J Psychiatry; 1990 Nov; 147(11):1493-7. PubMed ID: 2221162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder.
    Montgomery S; Chatamra K; Pauer L; Whalen E; Baldinetti F
    Br J Psychiatry; 2008 Nov; 193(5):389-94. PubMed ID: 18978320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.
    Charney DS; Woods SW; Goodman WK; Rifkin B; Kinch M; Aiken B; Quadrino LM; Heninger GR
    J Clin Psychiatry; 1986 Dec; 47(12):580-6. PubMed ID: 3536889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depression in panic disorder and response to alprazolam therapy.
    Pyke RE
    Arch Gen Psychiatry; 1989 Nov; 46(11):1053-4. PubMed ID: 2818142
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.